임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
31건 표시
- 1상모집 중단 (진행 중)· Metastatic Prostate Cancer (mCRPC)A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer
리드: 노바티스
- 1상모집 중단 (진행 중)· Rheumatoid ArthritisAn Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
리드: 노바티스
- 1상모집 중단 (진행 중)· Systemic Lupus Erythematosus, SLEAn Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
리드: 노바티스
- 1상모집 중단 (진행 중)· Metastatic Neuroendocrine Prostate CancerNEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerLuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
협력: 노바티스
- 1상모집 중단 (진행 중)· Newly Diagnosed and Recurrent GlioblastomaDose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
리드: 노바티스
- 1상모집 중단 (진행 중)· Sickle Cell DiseaseLong-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
리드: 노바티스
- 1상모집 중단 (진행 중)· Mycosis FungoidesTulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
협력: 노바티스
- 1상모집 중단 (진행 중)· Breast Cancer[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerPhase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
리드: 노바티스
- 1상모집 중단 (진행 중)· MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
리드: 노바티스
- 1상모집 중단 (진행 중)· Myeloid DiseasesDose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
리드: 노바티스
- 1상모집 중단 (진행 중)· Alzheimer DiseaseStudy of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
리드: 노바티스
- 1상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
리드: 노바티스
- 1상모집 중단 (진행 중)· B-cell Non-Hodgkin Lymphoma (B-NHL)Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
리드: 노바티스
- 1상모집 중단 (진행 중)· Breast CancerAlpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
협력: 길리어드, 노바티스
- 1상모집 중단 (진행 중)· MesotheliomaA Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerA Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
협력: 노바티스
- 1상모집 중단 (진행 중)· Glioblastoma MultiformeTrial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
협력: 노바티스
- 1상모집 중단 (진행 중)· Advanced Solid TumorsRollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
리드: 노바티스
- 1상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungStudy of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
리드: 노바티스
- 1상모집 중단 (진행 중)· Acute Lymphoblastic Leukemia ALLRibociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
협력: 노바티스
- 1상모집 중단 (진행 중)· Multiple MyelomaUp-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
협력: 노바티스
- 1상모집 중단 (진행 중)· EGFR-mutant Non-small Cell Lung CancerStudy of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
리드: 노바티스
- 1상모집 중단 (진행 중)· Multiple MyelomaA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
협력: 노바티스
- 1상모집 중단 (진행 중)· ALK-positive NSCLCStudy of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
리드: 노바티스
- 1상모집 중단 (진행 중)· Advanced Malignancies That Harbor IDHR132 MutationsA Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
리드: 노바티스
- 1상모집 중단 (진행 중)· Acute Myeloid LeukemiaRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.